fda

  1. FDA to do priority review for Verzenio

    Verzenio fails in advanced lung cancer treatment, but advances in breast cancer treatment
    • anonymous
    • Thread
    • cancer treatment eli lilly fda oncology
    • Replies: 0
    • Forum: Eli Lilly

  2. Ulipristal acetate to be reviewed by FDA

    Will this help out the 26 million women in U.S. who have got uterine fibroids?
    • anonymous
    • Thread
    • allergan fda
    • Replies: 0
    • Forum: Allergan

  3. Diabetes - Lilly's competition with Sanofi

    Lilly's Humalog Junior KwikPen will be available now in U.S. Lilly KwikPen vs. Sanofi Solostar. Which insulin pen is going to win the race?
    • anonymous
    • Thread
    • diabetes eli lilly fda sanofi
    • Replies: 3
    • Forum: Sanofi

  4. Diabetes - Lilly's competition with Novo Nordisk

    Lilly's Humalog Junior KwikPen will be available now in U.S. Lilly KwikPen vs. Novo Nordisk FlexPen. Which insulin pen is going to win the race?
    • anonymous
    • Thread
    • diabetes eli lilly fda novo nordisk
    • Replies: 3
    • Forum: Novo Nordisk

  5. Diabetes - Lilly's competition with Sanofi and Novo Nordisk

    Lilly's Humalog Junior KwikPen will be available now in U.S. Lilly KwikPen vs. Novo Nordisk FlexPen vs. Sanofi Solostar. Which insulin pen is going to win the race?
    • anonymous
    • Thread
    • diabetes eli lilly fda novo nordisk sanofi
    • Replies: 1
    • Forum: Eli Lilly

  6. FDA to do priority review for Avycaz

    FDA to do a priority review for Avycaz and take action in first quarter of 2018.
    • anonymous
    • Thread
    • allergan drugs fda
    • Replies: 2
    • Forum: Allergan

  7. FDA approves Verzenio

    FDA says okay to Eli Lilly's breast cancer drug Verzenio.
    • anonymous
    • Thread
    • cancer treatment drugs eli lilly fda oncology
    • Replies: 0
    • Forum: Eli Lilly

  8. Mvasi, first direct competitor to a billion-dollar cancer drug

    FDA approves Allergan and Amgen's biosimilar of Roche's Avastin.
    • anonymous
    • Thread
    • allergan amgen cancer treatment fda
    • Replies: 1
    • Forum: Allergan

  9. FDA halts Celgene

    Celgene forced to pause 5 trials using AstraZeneca’s Imfinzi and full hold on one trial.
    • anonymous
    • Thread
    • cancer treatment celgene drugs fda
    • Replies: 0
    • Forum: Celgene

  10. FDA tells Eli Lilly it can quickly refile NDA for hopeful Baricitinib

    Lilly will resubmit the New Drug Application for rheumatoid arthritis medication baricitinib, to the U.S. Food and Drug Administration (FDA), before the end of January 2018. The companies anticipate the FDA will classify the application as a Class II resubmission, which will start a new...
Top Bottom
Back